LGALS1 and non-Hodgkin lymphoma: In NHL research, Lykken et al. showed that Human NHLs expressed elevated Gal-1 compared with nonmalignant lymphocytes and that Gal-1 expression by lymphoma cells abrogated CD20 immunotherapy in mice.